A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.
Clinical trial NCT07069972 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07069972
- Sponsor
- Yipeng Liu
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-01
- Primary completion
- 2029-09-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.